Fertility Test Market
By Application (Male Fertility, Female Fertility),
By End Use (Home Care, Fertility Centers, Hospitals),
By Product (Ovulation Testing Kit, Fertility Monitors, Male Fertility Products),
By Mode of Purchase (OTC, Prescription, Online),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):
Global Analysis and Forecast 2022-2032
The global fertility test market showcased a revenue of USD 612.45 million in 2021 and is projected to witness a compounded annual growth rate (CAGR) of more than 8.3 % over the forecast period of 2022-2032.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
Fertility testing refers to medical and physical examinations that examine a person's capacity to conceive. Blood tests, pelvic exams, semen analyses, basal body temperature (BBT) monitoring, post-coital testing, transvaginal (pelvic) ultrasound examinations, hysterosalpingograms (HSG), hysteroscopy, and laparoscopy are among the procedures performed. They are valid and dependable and assist in choosing the best treatment option. The evaluation and treatment of fertility depend heavily on fertility testing. The methods used by fertility testing equipment measure the body's hormonal levels and provide hormone profiles. These hormone profiles of the people are based on their health conditions, such as the length of their cycles, fertility issues, or any medications or treatments they have been undergoing. A few fertility testing tools, including fertility monitors, provide results by identifying high ovulating days by keeping track of body temperature and other physiological variables. Declining fertility rates among men and women, rising numbers of women with conditions like PCOS, the development of advanced ovulation monitors, and the spreading knowledge of this testing device across the world are supporting business opportunities.
One of the main reasons influencing the market is the rising prevalence of disorders like polycystic ovarian syndrome (PCOS). Furthermore, lifestyle changes, increased stress levels, and obesity, which are brought on by a lack of exercise and alterations in eating habits, are all contributing to an increase in infertility rates globally. The introduction of technologically improved products to treat widespread infertility also positively impacts the market. In addition, major market participants are heavily spending on research and development (R&D) activities to produce pregnancy and ovulation test kits and consolidate all fertility information. In addition, there is a rise in the demand for highly accurate, user-friendly fertility monitoring. The growing use of artificial intelligence (AI) in sperm analysis is anticipated to support market expansion.
Participants in the fertility test market can expect to see strong growth prospects in emerging nations like China, India, Brazil, and Mexico. The demand for fertility and ovulation screenings in developing countries is anticipated to fundamentally surpass due to rising rates of infertility, rising prevalence of PCOS, and accessibility of fertility screenings through online business sites, drug stores, and retail shops/pharmacies. For instance, In February 2021, a partnership between ExSeed®, a business that offers sperm testing at consumers' homes, and Fertility Focus, the firm that produces the OvuSenseTM fertility monitor and the OvuSense® Pro clinical screening and medication tools.
Impact of the Russia-Ukraine War on the Fertility Test Market
Increasing the demand for reproductive treatments, which they attributed to the dangers Russian citizens face from a possible ban on surrogacy and the devaluation of their savings. In addition to surrogacy and the interconnections between Ukraine and Russia, Russian surrogacy has traditionally relied on the reproductive labor of women who migrate to or commute from nearby former Soviet states. Like all labor migrants, it has been stated that the sanctions, inflation, and decline in remittances have all had an adverse effect on their incomes, negatively impacting their families and the economies of their home countries. It will have an impact on both domestic and international fertility services.
Fertility Test: Market Scope
The fertility test market is primarily divided into four segments application, end-use, product, and mode of purchase. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The application segment is further categorised into male fertility and female fertility. The end-user segment is segregated into home care, fertility centers, and hospitals. The product segment of the fertility test market is bifurcated by ovulation testing kits, fertility monitors, and male fertility products. With respect to the mode of purchase, the industry is analyzed by OTC, prescription, and online. Each of these segments is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2017-2021 is provided in the report, whereas the forecast period of 2022-2032 is offered.
Female fertility will capture the highest market share within the camera-type segment
The market for fertility tests is anticipated to be dominated by the female testing segment. The availability of a wide range of fertility test alternatives and declining female fertility rates are some of the factors that contribute to the large share. The growing cases, including female hormonal changes, irregular, heavy bleeding, and uterine abnormalities, have raised the demand for female fertility test kits. These issues may also be responsible for the usage of female fertility tests and the large expansion of the market for these devices. Therefore, it is anticipated that during the coming few years, the market for female fertility testing will expand significantly due to the rapid improvement of technology, increases in the average age of first pregnancies, and the availability of less time-consuming standardised diagnostic tests in favour of laboratory testing.
The home care segment will witness the highest growth rate between 2022-2032
The home care sector is predicted to dominate the market for fertility tests. A sizeable chunk of it can be attributed to the dropping rates of both female and male fertility, the increasing desire for continuous health monitoring, and the growing acceptance of home monitoring. The main factors influencing the anticipated growth of this market segment for ripeness hereditary attributes testing are the patients' preferred choice to self-screen their health-related conditions and the increase in market players' efforts to raise awareness of the rich testing products that are readily available in the marketplace.
The ovulation testing kit segment will capture the highest market share in the coming years
The market for fertility tests is predicted to be dominated by the ovulation Predictor Kits segment. The market expansion is anticipated to be considerably impacted by rising pregnancies sustained because of health problems, ageing, or other factors worldwide. The convenience of use and nearly accurate results of these kits will all lead to a growth in demand for ovulation test kits during the projection period. Additionally, rising purchasing power and rising consumer knowledge of women's health are the two factors most likely to fuel market growth. Furthermore, manufacturers are currently focusing on developing new products that can deliver excellent outcomes at a lower cost while offering easy and reliable results. For instance, in 2021, Sugentech partnered with a significant producer of digital ovulation test kits and CGETC, Inc., a U.S.-based consumer fulfillment and marketing company.
OTC-based segment within the application to witness the highest CAGR during the forecast time frame
The OTC-based segment is expected to account for a larger share of the market
The sizeable share can be attributed to factors such as the increasing patients' preferences with at and remote monitoring, the usability of e-commerce, the confidentiality and accessibility of test results, and the expanding initiatives made by top market players to develop user-friendly products. The main factors influencing this market segment's constant growth are patients' interest in self-monitoring their health-related conditions and the rise in market participants' initiatives to enhance consumer awareness of the variety of fertility testing kits available in the marketplace.
North America to capture the highest market share in the fertility test Market
Due to the increased prevalence of PCOS (polycystic ovary syndrome), increasing first-pregnancy ages, and rising usage of fertility monitoring devices for contraception in North America, the area currently holds a dominant share of the global market. Another important aspect boosting demand for the fertility sector in North America is acceptance of technical improvements, rising disposable income, the existence of key players, and continued expansion in developed economies such as the U.S. In addition, the market will grow as a result of the rising geriatric population, product launches, and various regional market development plans.
Impact of COVID-19 on Fertility test Industry
The demand for fertility testing has been impacted worldwide due to the social distancing guidelines and restrictions. Due to the pandemic, many couples find it challenging to acquire fertility testing services. However, businesses in this sector have been developing cutting-edge strategies so fertility testing centers can continue operating while abiding by governmental regulations.
Fertility Test: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers and restraints opportunities impacting the fertility test market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the fertility test industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating the market are Abbott Laboratories, Advacare Pharma, bioMérieux SA, Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Procter & Gamble Co., Prestige Brands Holdings Inc., Quidel Corporation. These companies cumulatively hold most of the fertility test market share and actively undergoes strategic development, such as new product launch, mergers, collaborations, business expansion, acquisitions, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Driver: Rising first-time female ages, increasing awareness of cutting-edge fertility testing techniques
A woman's peak reproductive years are believed to be between her late teens and late 20s. Fertility begins to drop at age 30. (the capacity to become pregnant). This decline becomes more rapid once you are in your mid-30s. By the time most women reach the age of 45, their chances of spontaneous pregnancy have drastically decreased. However, a woman's likelihood of having a kid with extra, damaged, or missing chromosomes increases as she ages. Additionally, several reproductive treatments raise the possibility of multiple pregnancies. Multiple pregnancies can be healthy but can also raise the chance of preterm birth. These factors are responsible for market growth. The adoption of cutting-edge technologies has increased the efficiency and popularity of the fertility testing market.
Restrain: High Cost of Fertility Testing
The cost of ovulation testing kits and other fertility testing kits fluctuates. The brand and its level of popularity also influence the pricing. Because these testing supplies and fertility trackers are so expensive, underdeveloped nations may hold back and limit their use to individuals who can afford them. Thus, The high price of fertility testing inhibits a lot of clients from using these services and reduces market demand. In women over 40, several ovulation trackers perform less well. The ovulation test kit market has been adversely affected.
Opportunity: Increasing the awareness of the kits in emerging economies
Developing countries, including China and India, can take the initiative and improve the industry's all-around appeal on a global basis. There is an opportunity to make fertility testing regulations more liberal so that more people are aware of these services, and the market demand can increase. A growing number of contraceptive methods that monitor fertility is being used in this region, and social media, and marketing initiatives, are all assisting in spreading information about the benefits of ovulation monitors. Rising per capita incomes and the widespread usage of testing kits will develop new opportunities for the fertility tests market. Furthermore, there is an opportunity for current market participants to improve efficiency even further by incorporating cutting-edge technology and innovation into their current fertility testing processes.
Fertility Test Market: Recent Developments
- In January 2022, Kindbody, a leading fertility and family-building care company, unveiled the introduction of Kind at Home, its consumer products segment, in order to accompany people during their complete reproductive journey. Easy-to-use at-home fertility hormone tests for both men and women will be the company's initial offering.
- In February 2021, Fertility Focus partnered with ExSeed Health, a sperm testing business that is operated at home. Under this arrangement, the two businesses would work together to provide pregnant couples solutions.
- In April 2019, Fertility Focus, a major provider of fertility monitoring equipment that supports women who are having issues getting pregnant, will release a thorough update of the app for its OvuSense fertility monitor. The most recent app update provides a novel, personalized approach for OvuSense users to interact with their fertility data, which combines clinical accuracy with more user-friendly features.
- In April 2020, Mira introduced the "estrogen and luteinizing hormone test," a brand-new product. A novel at-home tracking technology accurately detects the whole fertile window with less than 99% accuracy, and the recently announced product performs well.
- In April 2016, Church & Dwight Co., Inc. announced the release of the "First ResponseTM Pregnancy PRO Digital Pregnancy Test + App Access." The recently launched product—the first and only pregnancy test stick with Bluetooth support—is now widely accessible throughout the nation.
Fertility Test Market: Synopsis
The study of the fertility test market offers revenue and growth data sets of segments provided at the global, regional, and country levels. The report offers the historical data set for 2017-2021 and the forecast period of 2022-2032. For the purpose of analysis, Quadrant Market Insights (QMI) has segregated the fertility test market into four major segments as follows:
By Application
- Male Fertility
- Female Fertility
By End Use
- Home Care
- Fertility Centers
- Hospitals
By Product
- Ovulation Testing Kit
- Fertility Monitors
- Urine
- Saliva
- Blood - Male Fertility Products
By Mode Of Purchase
- OTC
- Prescription
- Online
The regional analysis of the fertility test market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the fertility test industry are:
- Abbott Laboratories
- Advocare Pharma
- BioMérieux SA
- Church & Dwight Co. Inc.
- Fairhaven Health LLC
- Fertility Focus Limited
- Geratherm Medical AG
- HiLin Life Products Inc.
- Procter & Gamble Co.
- Prestige Brands Holdings Inc.
- Quidel Corporation
Fertility Test Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the fertility test market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the fertility test market analysis from 2017 to 2032 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the fertility test segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global fertility test industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Fertility Test Market: Frequently Asked Questions (FAQ)
Q: How big is the fertility test market?
A: The global fertility test market showcased a revenue of USD 612.45 million in 2021 and is projected to witness a compounded annual growth rate (CAGR) of more than 8.3 % over the forecast period of 2022-2032.
Q: Does the report have several fertility test numbers bifurcated by segments and regions?
A: The report offers a total number of fertility test numbers, further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the fertility test market?
A: The rise in late pregnancies across the globe and positive attributes towards using fertility test products to support the market over coming years.
Q: How can I get the sample Report on the fertility test market?
A: The fertility test market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Application
- End Use
- Product
- Mode of Purchase
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Rising first-time female pregnancy ages, increasing awareness of cutting-edge fertility testing techniques
- Increasing awareness about fertility testing kits in emerging economies
- High cost of fertility testing
Abbott Laboratories, Advacare Pharma, bioMérieux SA, Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Procter & Gamble Co., Prestige Brands Holdings Inc., Quidel Corporation.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Application Insights
2.5 End Use Insights
2.6 Product Insights
2.7 Mode of Purchase Insights
2.8 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Fertility Test Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on Fertility Test Market
3.13 Russia-Ukraine War Impact on Fertility Test Market
3.14 Growth Share Matrix
3.15 Fertility Test Market Quadrant
4. Fertility Test Market, By Application
4.1 Major Impacting Factors, By Application
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
4.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
4.2 Male Fertility
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
4.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
4.3 Female Fertility
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
4.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
5. Fertility Test Market, By End Use
5.1 Major Impacting Factors, By End Use
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
5.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
5.2 Home Care
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
5.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
5.3 Fertility Centers
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
5.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
5.4 Hospitals
5.4.1 Key Market Trends and Growth Factors
5.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
5.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6. Fertility Test Market, By Product
6.1 Major Impacting Factors, By Product
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.2 Ovulation Testing Kit
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.3 Fertility Monitors
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.3.4 Urine
6.3.4.1 Key Market Trends and Growth Factors
6.3.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.3.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.3.5 Saliva
6.3.5.1 Key Market Trends and Growth Factors
6.3.5.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.3.5.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.3.6 Blood
6.3.6.1 Key Market Trends and Growth Factors
6.3.6.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.3.6.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
6.4 Male Fertility Products
6.4.1 Key Market Trends and Growth Factors
6.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
6.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
7. Fertility Test Market, By Mode of Purchase
7.1 Major Impacting Factors, By Mode of Purchase
7.1.1 Key Market Trends and Growth Factors
7.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
7.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
7.2 Over The Counter (OTC)
7.2.1 Key Market Trends and Growth Factors
7.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
7.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
7.3 Prescription
7.3.1 Key Market Trends and Growth Factors
7.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
7.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
7.4 Online
7.4.1 Key Market Trends and Growth Factors
7.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Million)
7.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8. Fertility Test Market, By Region
8.1 Global Market Trends and Growth Factors
8.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.6 Market Size and Forecast, by Region, 2017-2032, (USD Million)
8.7 North America
8.7.1 Key Market Trends and Growth Factors
8.7.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.7.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.7.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.7.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.7.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.7.6 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8.7.7 U.S.
8.7.7.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.7.7.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.7.7.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.7.7.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.7.7.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.7.8 Canada
8.7.8.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.7.8.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.7.8.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.7.8.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.7.8.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.7.9 Mexico
8.7.9.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.7.9.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.7.9.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.7.9.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.7.9.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8 Europe
8.8.1 Key Market Trends and Growth Factors
8.8.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.6 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8.8.7 UK
8.8.7.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.7.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.7.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.7.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.7.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.8 Germany
8.8.8.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.8.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.8.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.8.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.8.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.9 France
8.8.9.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.9.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.9.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.9.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.9.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.10 Russia
8.8.10.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.10.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.10.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.10.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.10.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.11 Italy
8.8.11.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.11.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.11.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.11.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.11.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.8.12 Rest of Europe
8.8.12.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.8.12.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.8.12.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.8.12.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.8.12.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9 Asia-Pacific
8.9.1 Key Market Trends and Growth Factors
8.9.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9.6 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8.9.7 China
8.9.7.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.7.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.7.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.7.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.7.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9.8 India
8.9.8.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.8.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.8.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.8.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.8.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9.9 Japan
8.9.9.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.9.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.9.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.9.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.9.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9.10 Australia
8.9.10.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.10.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.10.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.10.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.10.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.9.11 Rest of Asia-Pacific
8.9.11.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.9.11.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.9.11.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.9.11.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.9.11.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.10 Latin America
8.10.1 Key Market Trends and Growth Factors
8.10.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.10.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.10.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.10.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.10.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.10.6 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8.10.7 Brazil
8.10.7.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.10.7.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.10.7.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.10.7.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.10.7.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.10.8 Argentina
8.10.8.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.10.8.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.10.8.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.10.8.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.10.8.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.10.9 Mexico
8.10.9.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.10.9.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.10.9.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.10.9.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.10.9.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.10.10 Chile
8.10.10.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.10.10.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.10.10.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.10.10.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.10.10.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.11 Middle East and Africa
8.11.1 Key Market Trends and Growth Factors
8.11.2 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.11.3 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.11.4 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.11.4.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.11.5 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.11.6 Market Size and Forecast, by Country, 2017-2032, (USD Million)
8.11.7 South Africa
8.11.7.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.11.7.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.11.7.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.11.7.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.11.7.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.11.8 UAE
8.11.8.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.11.8.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.11.8.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.11.8.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.11.8.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.11.9 Saudi Arabia
8.11.9.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.11.9.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.11.9.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.11.9.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.11.9.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
8.11.10 Israel
8.11.10.1 Market Size and Forecast, by Application, 2017-2032, (USD Million)
8.11.10.2 Market Size and Forecast, by End Use, 2017-2032, (USD Million)
8.11.10.3 Market Size and Forecast, by Product, 2017-2032, (USD Million)
8.11.10.3.1 Market Size and Forecast, by Fertility Monitors, 2017-2032, (USD Million)
8.11.10.4 Market Size and Forecast, by Mode of Purchase, 2017-2032, (USD Million)
9. Competitive Benchmarking & Company Profiles
9.1 Competitive Benchmarking
9.1.1 Company Market Share
9.1.2 Product Mapping
9.1.3 Competitive Heat map
9.2 Amalgam Biotech
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Product Offering
9.2.4 Strategic Initiatives
9.2.5 SWOT
9.2.6 Ansoff Matrix
9.3 Bioscience, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Product Offering
9.3.4 Strategic Initiatives
9.3.5 SWOT
9.3.6 Ansoff Matrix
9.4 Drylet, LLC
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Product Offering
9.4.4 Strategic Initiatives
9.4.5 SWOT
9.4.6 Ansoff Matrix
9.5 Microgen Biotech Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Product Offering
9.5.4 Strategic Initiatives
9.5.5 SWOT
9.5.6 Ansoff Matrix
9.6 Novozymes
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Product Offering
9.6.4 Strategic Initiatives
9.6.5 SWOT
9.6.6 Ansoff Matrix
9.7 Organica Biotech Pvt. Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Product Offering
9.7.4 Strategic Initiatives
9.7.5 SWOT
9.7.6 Ansoff Matrix
9.8 Probiosphere
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Product Offering
9.8.4 Strategic Initiatives
9.8.5 SWOT
9.8.6 Ansoff Matrix
9.9 QM Environmental Services Nederland
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Product Offering
9.9.4 Strategic Initiatives
9.9.5 SWOT
9.9.6 Ansoff Matrix
9.10 Shandong Sukahan Bio-Technology Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Product Offering
9.10.4 Strategic Initiatives
9.10.5 SWOT
9.10.6 Ansoff Matrix
9.11 Thermo Fisher Scientific, Inc.
9.11.1 Company Overview
9.11.2 Financial Analysis
9.11.3 Product Offering
9.11.4 Strategic Initiatives
9.11.5 SWOT
9.11.6 Ansoff Matrix
10. Industry Connects and Upcoming Seminars
.webp)
